EuroQuity Blog
Save the date for the next Belgian e-pitch Session on the 11th !

Next Belgian e-pitch session will take place on  Thursday June 11th at 5 p.m.

5 companies active in #healthcare IT, #foodtech, #edtech, #mobility app and #labtech are looking for just over € 1,500,000 for their growth.

Curious to know more, attend the EuroQuity epitch Tuesday 11th of June by registering here

The selection is as follows:

Healthcare IT
The startup has developed unique and innovative patient-centred tools enabling a more personalised and participatory medicine. Their tool is used by diagnosed cancer patients to receive personalised information enabling them to take better part in their treatment choice in a Shared Decision-Making environment, as well as further monitor their health status during and after treatment to provide them and their care team with actionable insights. Furthermore, the tool can ease trial participant recruitment through trial Patient Decision Aids with a first screening of admissibility as well as remote monitoring of participants. The tool is envisioned to leverage, inter alia, the power of predictive models to propose individualised information to the patients. The first client is a clinical trial that takes place in multiple European hospitals enabling them to generate early revenues and receive feedback from a first userbase. Interest from UZ Gent, CU St Luc, the Bordet Institute, UMC+ Maastricht and UCSF |€ 200K sought

Edtech | Secondary school digitalized education
According to education figures, secondary school students loose, on average, up to 6 weeks of lessons per school year, due to the lack of teachers. On top of this, teachers/students absenteeism, is not included in the figures. We make a tool that ensures continuity of learning and retains contact between teachers and students on regular basis. To add to this, the current unique crisis brought a new figure to our understanding : 5 to 10% of secondary students disappeared from school radars, due to a lack of equipment and difficulties related to the use of the proposed solutions. Target: all secondary schools and students | € 120k sought 

Foodtech – More innocent then it tastes
Incredibly tasty, sustainably packaged ice desserts with a daring slug of alcohol. What is the sweetness to our success? A mixture of cane sugar and Stevia of course! We also let you enjoy 100% real fruit, sustainable milk and cream from happy pasture cows, and nothing but the finest Belgian chocolate. And that slug of LiQueur? That's for that extra kick that you won't find anywhere else. Cheers! Clients : Delhaize, Spar, Carrefour, Costco France and many more in our pipeline. | € 400k sought

Mobility management Application for businesses
Transform your parking turmoil into a seamless process with ease using our SMART Parking: Put the right vehicle in the right spot at the right moment! With our app, each parking spot is controlled in real-time by its digital signage connected to complementary management tools, allowing dynamic priority allocation and instantaneous use. Cherry on the cake, thanks to the Spatio-temporal control, each spot can switch momentary into parking sharing mode as a way to engage in social responsibilities.  We are now developing a solution dedication to businesses. Target: universities, hotels, residences, companies in Belgium| €300 k sought for development of the business solution

Labtech | To avoid patient's misdiagnostics.
Up to 40% of medical diagnostic tests for respiratory diseases in the laboratory are falsified by a false negative result which delays patient care. The startup developed and provide an unique non-invasive medical device for sampling and sample management solution ensuring sampling of choice with optimal quality stability and traceability from collection to the laboratory. The benefits for the patient is comfort, rapid and precise diagnosis, while that of the laboratory ones are efficiency, reduction of the Risk management and unnecessary costs. 3 patent portfolios are protecting all of our technologies globally. The first laboratory orders are in progress | Scientific partnership in progress with the LHUB-ULB | € 500k sought in seed capital

Tuesday, June 2nd 2020

We are very pleased to announce you the second e-pitch session we are organising in collaboration with Solar Impulse foundation on June 9th at 17:00 CEST.

Join the Solar Impulse e-pitch session on June 9th at 5:00pm CET

The second E-pitch exclusively for Solar Impulse Labelled Solutions.
Witness 6 of the finest startups pitching to you directly online.

You can register by clicking here

Here is the selection: 


Cleantech/Water – Water filtration system to provide drinking water for up to 20 000 people
First French start-up in water filtration with social utility accreditation (ESUS), having developed innovative water filtration systems for drinking water access in developing countries for communities from 500 up to 20 000 people.
Our technologies do not require any chemical nor consumable, and our filters stay operational and safe for 10 years. For €0,52 / m3, we can supply the 1.8B people who have no safe drinking water access worldwide.
Main customers: NGO, public authorities, international organizations | TRL: 8 | TAM: €23bn 0.5M€ sought - France
Cleantech/Energy – IoT microturbine for data-driven management of gas/water networks
The company is a spin-off of the Italian Institute of Technology and developed a coin-sized microturbine that harvests up to 150W of electricity off-grid from gas pipelines. It recovers otherwise wasted pressurized natural gas energy. It is currently sold to a number of gas utilities in Italy, and was recently pilot-tested in Latin America. The company is H2020 funded and won several innovation awards, and the technology is ATEX certified for operation in hazardous environments with gas presence. A water microturbine is now under development.
5 customers in Italy, including utilities and an international corporation | TRL: 9 (gas) and TRL 7 (water) | TAM (water): €2bn | Next Step: industrialization and commercialization of water microturbine | 0.5M€ sought - Italy

Cleantech/Energy – Turning hydrogen into a fast-moving consumer good
Spin-off from a company with a successful track record turning innovations into global standards: 30 million vehicles already on-the-road. In 2020 we will launch the new hydrogen storage standard with vehicle manufacturers that have adopted our cartridges:  complete range of 2/3/4 wheel vehicles. Universal, adapted to all light mobility markets, zero-pressure, no distribution infrastructure, 100% green, 100% recyclable, rechargeable at home, more competitive than batteries. 
100+ patents worldwide | TRL: 8 | TAM: €30bn | Next Step: industrialization | 20M€ sought - Switzerland

Renewable energy / Renewable gas
Reduce CO2 in energy intensive manufacturing industries by transforming a costly waste issue, e.g. MDF-dust, into high quality process heat or combined heat and power.
Finalist in SET-Awards, winner of EU-China cleantech competition, Winner of BOIS Energie Innovation competition. Concrete project opportunities together with multinational companies in tissue industry (50% national grant secured) and furniture industry. From LOI to agreement stage in several discussions | TRL: 8 | 8-12M€ sought - Sweden

Cleantech/waste treatment – Mycoremediation of complex soil contamination
With about 2.8 million contaminated sites and annual expenditures of €6.5 bn, soil pollution constitutes an important environmental and economic challenge in Europe. Our unique approach relies on an innovative biotechnology platform that converts low-grade green waste into a bioremediation medium. We introduce an efficient, competitive (> 50% cost reduction), impactful (-70%CO2 emissions) new way to treat heavily contaminated soils. Driven by the vision that future generations deserve to thrive on a clean and healthy planet, our mission is to design impactful, circular and economically sound solutions to bring soils back to life.
Strong industrial partnerships | TRL: 6 | TAM: €3,7bn | Next Step: industrialization | 1.5M€ sought in 2020 (0.5k for closing) and a 3M€ Series A in 2021-2022 - Belgium

Cleantech/Agritech – Extracting Value from Carbon
This Carbon removal technology has created a range of widely patented and commercial “Climate positive” processes that realise value across the whole waste inventory. These are now being installed by major organisations to enhance their businesses. We use captured CO2 and waste to trigger significant Carbon retention and ESG premiums. The first of four applications to commercialise the core technology produces high performance “Climate Positive” fertilisers, from low or negative value inputs/feedstocks.
48 patents worldwide; 29 pending | 3 contracts 2020 (with potential for multiple orders) | TRL 9 | TAM €141bn | Next step: Intl expansion | 16M€ sought - UK

> Register here

Tuesday, June 2nd 2020
Join the InvestHorizon e-pitch Session on June the 9th at 5:00pm
Our next InvestHorizon pitch session will be held online on June the 9th at 5:00 PM CEST.
8 HealthTech companies will be presented.
All these Serie A companies are part of the European InvestHorizon acceleration program, and are looking for funds to continue their growth.

Here is the list of the 8 deeptech companies:

MedTech/ Cardiovascular implant
We develop a stent like implant to correct mitral regurgitation, thus preventing heart failure. This trans vascular device “Mitral Butterfly” will be delivered via a steerable catheter semi-automatically. Unlike many other mitral artificial implantations, the procedure is a simple, one-step performance, to be used by any interventionists in a variety of mitral pathologies. This award winning, proprietary technology with internationally granted patents, has been tested in silico and in chronic animals showing 100% procedural success and durability up to 90 days. | 10M€ sought – Austria

Detect Lynch syndrome, prevent cancer. Lynch syndrome is the most common hereditary cancer predisposition, but vastly under diagnosed today. We provide easily interpretable and highly accurate results even before cancers develop, enabling preventive and personalized care. CE-marked as IVD MD, validated and launched in domestic market. LOIs signed with leading hospitals across Europe. Accelerated by InvestHorizon and EIT Health. | 5.0M€ sought – Finland

HealthTech / Medical Devices
Intraocular pressure monitoring contact lens system for better glaucoma and ocular hypertension management. Continuous 24-hour IOP monitoring provides vital information to prevent glaucoma, a leading cause of preventable blindness affecting 70 million people globally. SME Instrument Ph-I Champion, Hello Tomorrow Deep Tech Pioneer, Hello Tomorrow Turkey Challenge Runner-up, Doktorclub - Healthcare Initiative – R&D / Innovation Implementation Award | 3.1M€ sought – Turkey

HealthTech / Medical Devices
Produces hip and knee implants made of MP-1™ material self-lubricating, no-wear which lasts in the body for 30 Years. Has CE mark. Now in Post Marketing Clinical Study (PMCS) in 4 centers. Task: to improve life quality - enable surgeries in younger patients and reduce suffering. Partner with Enztec - a TOP orthopedic company in NZ. Winner of ORS award (USA), and of IMEACM award (China), MOU signed with several orthopedic companies (Mathys, Symbios, Ceramtec etc.) | 10M€ sought (in stages) – Israel

A development stage biotech company focused on novel therapies for the treatment of cancer. We are currently working on an innovative therapy for the treatment of malignant mesothelioma with a unique mechanism of action (RNA targeting
drug) that is currently completing non-regulatory data and advancing up to first-in-man clinical trials. Innovative SME seal from Spanish Ministry | 6.4 M€ sought – Spain

BioTech/ Therapeutics
We are developing a pipeline of synthetic genetic therapy treatments - a completely new non-viral therapeutic approach, recently extended to vaccination - that aims to solve the problems that existing gene therapy technologies face. iLab Laureate – Finalist of Tremplin Senat Award – Nominated amongst the top innovative companies in Gene Therapy by MedicalStartups and InsightsCare – Finalist of European Start Smart Global competition - Winner of the Galien-MedStartUp - Winner of the Innovation & Excellence Prize by Corporate Live Wire | 2.5M€ sought – France

Engineered-Chemistry/Sono-Coating/Anti-Bacterial Textiles
We are developing a single-step, sono-coating process, utilizing a unique physical phenomena called cavitation. This process eliminates the need for any chemical binders, greatly reducing the required chemicals in the coating process while allowing for a highly homogenized, high- performance coating with maximum dispersion. First coating on the market is antimicrobial, odor safe, sustainable, and durable to harsh industrial laundries. We are currently working to raise the necessary funds in order to scale-up and commercialize and bring their life saving technology to the marketFashion For Good - Plug & Play, Alumnus, Scaling Program, Horizon 2020 SME Program, Strategic partners : Bruckner I 5M€ sought - Israël
> Register here

Tuesday, June 2nd 2020

Meet eight high potential companies selected by the European Innovation Agencies - Taftie - on June 16 at 05:00 PM CEST

Join the Taftie E-Pitch session on June 16th at 05:00 PM CEST
We proudly present the 8th edition of the Taftie e-pitch session that will be held online on June 16th at 5:00 PM CEST. If the schedule does not fit you, register anyway , so you will still be able to watch the recorded session.   
This session will feature companies in biotech/medtech, AI / 3D Xray, AgriTech, looking for tickets from 0.5 to 10M€.

Companies were selected in collaboration with Taftie, the association that gathers all innovation agencies of European countries. This is a unique opportunity to discover from your office high-potential profiles from all over Europe and to ask them questions by registering here.

See you next June the 16th at 5:00 PM CEST. If you have any questions, do not hesitate to contact Cristina Chumacero.

Here is the program:

Implantable biomaterial scaffold device for the spinal cord repair following traumatic injury. There is no therapeutic option for injuried patients except a lifetime paralysis burden and a huge cost to society. Based on preclinical data in rats, our device has the potential to avoid degenerescence of the injuried spinal cord, allowing strutural tissue repair and functional recovery including locomotion. Technology transfer budget awarded by SATT Lutech in Paris, Preparing a first in man clinical trial starting in 2023 | TRL 6 |  TAM Western countries : $25B | Next step : seed financing| 0.5M€ sought – France

AI / 3D Xray
We close the industrial gap from sample-based to 100% quality inspection. Our AI-based “Accelerated 3D Xray Inspection” is image-based and fully automated for use on the production floor. Our ambition is that our technological breakthrough will become the new Quality 4.0 Inspection standard for Automotive, Medical/Pharma, Additive Manufacturing & Critical assemblies. | TRL: 5-7 | TAM: 3-10B€ | Next Step: market entry and industrialization | 3.0M€ sought – Belgium

Healthcare software
The company is a software-based solution developer for the healthcare industry, to trace treatments, covering from prescription to their administration.  Treatment safety is paramount and a traceability system much like in the food industry to ensure safety is the future for treatments. Best system in the administration control of oncologic patients from Teknon Foundation 2013 - Most innovative system in the preparation and administration of dangerous medicines from the Spanish Hospital Pharma Society 2014 - Unidosis project received “Excellence R&D Project Award” and grant from CDTI, 2018 - Innovative SME from IPYME Innovadora 2019. Cooperation agreements signed with international Pharma companies Bristol Myers and Novartis. | TRL 9 | TAM:9.6T | Next step: commercial acceleration | 6M€ sought – Spain

SaaS / AI / Agri-Tech
Software that uses AI to analyze complex data patterns from aerial imagery (gathered by drones, satellites...) of crops, fields, and forests, in order to extract accurate digital data of value for improving agricultural processes. So far around 2000 users from over 100 countries paid to use our service. We have customers and partners among world-leading industry players and multinational agribusinesses. | TRL 9 | Next step: scaling up and strengthening go-to-market channels, further shortening R&D cycles. | €1.5M sought - Serbia

Health Care / Cardiovascular  
We do patient-specific blood flow simulations for cardiovascular pre-surgical planning. We provide optimal surgical configurations in silico leading improved quality of life, multi-organ function and shorter operation time for the patients and surgical centers. Received CE mark recently as a Class IIa device and 3 international patents - Used over 200 patients globally and seed clinical trial done – A European Research Council, Proof-of-Concept spinoff – Winner of top entrepreneurship awards | TRL: 8 | TAM: $100M | Next Step: service to new clinical centers/markets | 1.0M€ sought – Turkey

Internet of Things / Environment / AgriTech

A set of smart IoT sensors, cloud solution, artificial intelligence, communication tools and devices for beehive environment detection and healing of beehives. Bees are an extremely endangered element of the planet's ecosystem and are a prerequisite for food security. The company already sells its products in 45 countries around the world. Gold Prize at the Slovak exhibition AGRO, 1st place in the Slovak round and 2nd place internationally at the Social Impact Chivas Venture Voting. | TRL 9 | TAM: $ 27B | Next step: business acceleration | 2 M€ sought – Slovakia

Clinical Diagnostic / Point of Care (POC) Testing
With our instrument, rapid identification of bacterial infections such as urinary tract infections (UTI’s) and bacterial co-infections reported with COVID-19 victims becomes possible at POC in less than 30 min. Cumbersome and time consuming microbiological culture tests (3-4 days) become herewith obsolete. Precise and rapid diagnosis at the doctors’ office or hospital ICU is within reach, allowing for proper medication, reducing the risk of antimicrobial resistance (AMR), and saving lives. Finalist of the 2019 Dutch National Icon. Contract for clinical validation and subsequent piloting at GP group practice signed with leading Dutch 1st line microbiology laboratory | TRL : 6 | TAM : $23B | Next Step : Clinical validation| 10 M€ sought – The Netherlands

IOT / Industry 4.0 / Big Data

For investors looking to benefit from a burning global need of optimization and costs cutting in the industry sector: we are solving essential technology challenges of indoor vehicles positioning. We developed and validated our solution together with manufacturing leaders like Toyota, Bridgestone and Opel. It consists of BI software and tracking hardware, which is non-invasive to plant’s infrastructure. Finalist of accelerator programs: Industry Lab II | KPT ScaleUp | Space3AC ScaleUp
TRL: 7-8 | TAM: $9B | Next Step: commercialization | 1.5M€ sought – Poland


Monday, May 18th 2020
Pssssst …. We have some exciting news ! Introducing the Innovation Fund Serbia label on EuroQuity!
The Innovation Fund  of the Republic of Serbia  … does the name ring a bell? It’s a Governmental agency aiming to foster the development of high-value products and services and promote innovation entrepreneurship. Interesting isn’t it? Well that’s what we thought too and so we invited them to join the EuroQuity family. Through the Innovation Fund  Serbia Label , the Innovation Fund Serbia is striving to promote high-potential Serbian companies with smart business models, looking for series A investment.

The Innovation Fund of the Republic of Serbia  wishes to give a better overview of the booming Serbian ecosystem and its high-potential startups to private investors. Therefore, this label is looking to promote companies whose development is based on the innovative approach of problem solving, with a well-defined roll out strategy led by talented and enthusiastic teams.
Overall, the Innovation Fund of the Republic of Serbia support Serbian SMEs in their efforts to design, develop and place their innovative products on the global market through various financial instruments:

Mini Grants Program : a seed program intended to help early stage startups to complete their R&D phase and create a sustainable go-to-market strategy.

Matching Grants Program: stimulates further knowledge-based development of innovative enterprises and encourages establishment of liaisons with international partners or investors.

Collaborative Grant Scheme Program : grant scheme intended for joint projects of SMEs and R&D organizations to create new products and services as innovative technologies with significant future impact and high market potential.

Technology Transfer Facility Program: support for RDI researchers to bring their research to the market.

Proof of Concept Program : financial and mentoring support for RDI researchers to test their ideas that could lead to marketable products and services.

Innovation Vouchers : simple financial mechanism that enables SMEs to use the R&D services of the RDIs.

To find out which startups are part Innovation Fund Serbia Label, click here
For more detailed information:

Tuesday, May 12th 2020

5 top solutions to help fight Covid-19, selected by VC partners.

European entrepreneurs presenting solutions for managing COVID - 19th of May at 17:00 CEST
The selection of 5 companies was made from various sources of European programmes involving innovative startups, and shortlisted by VC partners, all these entrepreneurs are  looking for funding from  1.5M€ to 30M€ and they will be pitching for 8 minutes each next Tuesday, May 19th, at 5 pm CEST.

This session is dedicated to diverse industries such as HealthTech, MedTech, AI and BioTech, check the program below.

If your schedule is too busy, you will still be able to watch the recorded session by registering.

Don’t miss it!

Medtech / Respiratory Diagnostic-COVID
We are an industry leader in respiratory monitoring for our patented wearable. A novel and quickly adopted clinical decision support tool identifies patient deterioration 6 or more hours earlier than the standard of care. It has shown to be a highly sensitive marker of deterioration, being 99% accurate when abnormal blood chemistry is present. It is an essential tool for patients at risk of Respiratory Compromise and especially for COVID-19 positive patients. Presently our patented wearable is being used in 40 beds with 200+ beds being implemented across the next 6 weeks in Ireland and the UK. The emerging serviceable market opportunity is in excess of €2.5Bn. PMD is seeking €3.5m of equity funding of which €1.4m has already been committed. The use of funds is to scale market awareness and establish reimbursement coding which will bring the company into profitability. | Capital sought: €3.5m - Ireland

Biotech/ severe Covid-19
We develop a peptide drug, for severe cases of Covid-19, namely those with a generalized inflammation of the endothelium affecting lung, heart and kidneys and leading to multi- organ failure. The drug has anti- inflammatory efficacy and prevents edema formation by “sealing up” the damaged inner layer of small blood vessels i.e. the endothelium. FX06 has a very benign safety profile and might – beyond Covid-19 patients – be an effective treatment option in other severe diseases associated with capillary leak and inflammation.
First Covid-19 patients have been treated with FX06 and a ph II controlled study will start in June Capital sought: 1.5M€ - Germany, Austria, France, Italy

Biotech / repositioning EMA-approved drugs for COVID-19
We are leaders in therapeutic target discovery and drug repositioning. We implement computational AI-driven drug identification to an accelerated therapeutic validation technology to more efficiently reposition EMA-approved drugs. In applying this novel approach, we have identified clinical and pre-clinical drugs capable of maintaining cell viability and function in the face of toxicity-induced cell death. The drug candidates we have identified specifically prevent two key aspects of COVID19 disease progression, namely the amplification of viral particles and cell death, and the induction of tissue hyperinflammation leading to adverse outcome and death in patients.
H2020 SME Instrument Phase 2 winner (2.42M€) and a JLABS resident company, we have developed a rich pipeline in Hypertrophic Cardiomyopathy, Cardiotoxicity, Heart failure & Rare Disease, with our first compounds (10M€ partnership deal) - to enter Phase 1 clinical trials in 2021 Capital sought : 4.6M€ (1.1M€ for simultaneous in vitro / in vivo studies, 3.5M€ for subsequent Phase 1/2 clinical trials) - Germany 

Medtech / Bio-decontamination
Delox developed dryVHP, a solid formulation of hydrogen peroxide (oxygenated water). Besides highly effective (eliminating 99.999% of the microorganisms), safe, and environmentally friendly bio-decontamination agent, it simplifies the design of automatic bio-decontamination devices, outstripping currently marketed equipment by being compact, robust, and energy-efficient. Our mission is to deliver bio-decontamination to everyone, everywhere.
We have raised €175k of non-dilutive funding (European Space Agency, EIT Health and SME Instruments I), and €300k from VCs. So far, we have filed two patents, and executed 3 successful field tests with the Portuguese Army and Decontamination Specialty Equipment Inc, PA, USA. In the next three months, we are developing two bio-decontamination chambers to decontaminate protective respirators allowing their reuse by healthcare workers, and we are also working with bio-decontamination experts to pilot our solution in compounding and hospital pharmacies in the USA. Capital sought: €1 M – Portugal 

Digital Health / AI
Our digital health assistant helps you understand what might be wrong if you are feeling unwell. Simply state your symptoms and answer questions to find possible diagnoses. It is based on 14 years of scientific research by medical doctors and data scientists to help patients receive their right diagnosis and treatment.
Today, it is the most used symptom checker worldwide among both doctors and patients with millions of users and searches per month. Its diagnostic accuracy is raising the bar in its industry and has been validated in internal, external, and peer-reviewed scientific publications comparing up to 107 symptom checkers worldwide where it clearly ranked as #1. The company is operating at a profit. Capital sought : 30M€ - Austria

Tuesday, May 12th 2020

We are very pleased to announce you the very first e-pitch session we are organising in collaboration with BlueInvest on May 26th at 05:00 PM CEST.

Join us for the first edition of the BlueInvest e-pitch session on Tuesday 26th at 05:00 PM CEST
We are proud to present the first edition of the BlueInvest e-pitch session, which will be held online on Tue 26 May at 5:00 PM CEST, you can register here.

This session features European companies with sustainable technologies for the Blue Economy, in ICT, Robotics, Blue renewable energy, Aquaculture and Blue biotechnology.

The companies were selected in collaboration with BlueInvest, an initiative of the European Commission to promote innovation and access to finance for SMEs and start-ups with sustainable technologies for the Blue Economy.

We hope to see you on Tue 26 May, 5:00 PM CEST. If you are interested but not available, you are welcome to register to have access to the recorded session. 

If you have any questions, please contact Cristina Chumacero,

Aquaculture / Blue biotechnology
We offer a smart urban farm that grows and provides sustainable, fresh, local, tasty and healthy fish and vegetables to urban consumers, using our own developed Hi-Tech Aquaponics integrated solutions. Experienced knowledge in RAS; highly efficient hydraulic and filtering design with additional water savings and improved waste management; higher food safety and productivity; better real time monitoring and control; lower maintenance requirements. It is a scalable urban integrated system which successfully uses aquaponics in a natural, sustainable and transparent way to consumers.
Market classification: On-track to commercialisation | Next step: Commercialisation | € 0.5 - 3M sought – Portugal

We developed a fish cage that enables aquaculture operations at sites that are currently not feasible, in a manner that enhances safety, reduces disease and eliminates environmental impact. Salmon producers would buy this product to access new production capacity opportunities. Our solution allows safe and competitive fish production at new geographic locations for which aquaculture licenses will be more readily available. Capital costs of our structure are an order of magnitude lower in comparison to rival proposals for exposed locations. We have also focused on eliminating the need to depend on the incumbent offshore supply vessel and port infrastructure to ensure global applicability of the solution. Our solution reduces / eliminates the impact of effluent from fin fish aquaculture by operating at highly dispersive sites. We are in a technology demonstration in JV with a customer.
Market classification: Prototype, pre-commercial | Next step: Commercialisation | € 0.5-3m sought – Ireland

Robotics / Underwater drones
We support explorers, scientists, and industrial innovators with intelligent underwater robots. In 2020 we are planning to release a high capacity hybrid underwater vehicle capable of both autonomous and remote operation. It enables autonomous navigation and an automatic report generator. Our underwater robots are super easy to use, modular (new features can easily be added in the future), with a competitive Total Cost of Ownership.
Market classification: Successfully commercial | Next step: Global scaling | € 0.5 - 3m sought – Spain
Blue renewable energy
We have a turn-key solution for electricity production and desalination (potable water) based on wave energy. It is a scalable and non-intrusive system – does not spoil the view and has low environmental impact. Competitive cost of energy and water. Our technology reduces carbon emissions and increases use of renewable energy. In first step we focus on small islands and coastal communities to replace diesel generators as a main power supply, being able both to produce electricity and potable water.
Market classification: Prototype, pre-commercial | Next step: Commercialisation (2022) | €3 - 7m sought – Denmark

ICT for maritime
We are a new-maritime company known for having developed Waze for the Sea. We have developed IoT, Big Data and Machine Learning technologies to enable an unprecedented understanding of ocean dynamics. We have an own technology applicable to the maritime and space sectors. We also have dedicated team that provides professional services to Oil & Gas companies, Department of Defense and Space agencies. Our solutions to protect the environment, drive down costs, improve safety and deliver new growth.
Market classification: Prototype, pre-commercial | Next step: Commercialisation | France

Monday, May 11th 2020

We are very pleased to announce you the very first e-pitch session we are organising in collaboration with Solar Impulse foundation on May 7th at 17:00 CEST.

Save the date and join the Solar Impulse e-pitch Session on May the 7th at 5:00pm

What to expect?

  • Prior to the Pitch’Conference, Pascal Lagarde - Executive director in charge of International, Strategy, Studies and Development at Bpifrance and Bertrand Piccard - Solar Impulse Foundation Chairman, will do a keynote introduction.
  • The first-ever E-pitch exclusively for Solar Impulse Labelled Solutions.
    Witness the 5 of the finest startups pitching to you directly online.
You can register by clicking here

Here is the selection:

Blue-Green Tech/Construction Tech – Building resilient coastlines & increasing ocean health (Israël)
Developed to bridge the gap between the ever-growing need in coastal development and the need in sustaining marine ecosystems and resources, this scale-up brings concrete infrastructure to life through a patented win-win solution. The technology platform can help transform barren concrete based coastal and marine infrastructure like seawalls and breakwaters into a thriving habitat. The concrete solution has been successfully applied in 30 locations across 8 countries and 7 seas. Currently, the company is actively negotiating licensing the technology to key industry players.   
Global patents & TM | TRL: 7 | TAM: €30bn | Next Step: industrialization | Amount to raise: €2m

ML/IoT/Water/PropTech/InsurTech - Non-intrusive and real-time leak detection with proven ROI for insurance companies and building managers (Belgium) 
1 in 3 buildings present costly leakages, increasing water bills between 10-60% and costing european insurers 12 billion €/year in damages. By combining a patented, non-intrusive IoT sensor and proprietary machine learning, the service helps organisations cut water bills by 20% and nearly halve water damage claims. The technology has been recognised internationally by insurance companies and is already helping major belgian real estate owners save over 1M€ annually with a 12 month payback time. The start-up is looking to expand its business model and technology across the european property market and prepare its first roll outs with insurance companies.
Proven B2B sales to over 50 organisations | Paid pilots with EU insurers | TRL : 8 | TAM : €30bn worldwide | Amount to raise : €1.5m

Cleantech/Energy - Clean and innovative chillers based on magnetocaloric effect for cooling and wasted heat purposes (France)
French based start-up, develops magnetic chillers based on the magnetocaloric effect for the refrigeration and the air conditioning. These systems use no refrigerant gas, limiting the impact on global warming and consume up to 50 % less energy compared to gas compressors. Has also recently designed a breakthrough conversion device of wasted heat sources (<100°C) into electrical energy. With world renowned experts in this field, several prototypes tested in real life conditions and a strong intellectual property. Also, recognized as a leader in the magnetocaloric industry.
200+ patents worldwide; A breakthrough innovation | TRL: 7 | TAM: € 5bn | Next Step: industrialization | Amount to raise: € 6m

Cleantech/Chemicals - Sustainable and cost-competitive materials production (Switzerland)
Spin-off from a Swiss University, the start-up has developed a technology to efficiently isolate each fraction from biomass with unprecedented selectivity and yields. A chemical stabilization strategy suppresses degradation pathways to access, for the first time, high-value markets such as cosmetics, fragrances or biodegradable polymers. The technology has been scaled to the kilogram and the market has been de-risked.
3 patents worldwide ; 9 ongoing projects | TRL: 6 | TAM: €300Mn | Next Step: Demonstration | Amount to raise: €2.5m

Biotech/Agriculture – microalgae derived bio-inputs to sustainably increase agricultural yields (Spain)
Pioneering and multi-awarded biotech company devoted to microalgae with extensive research history and network, reputed shareholders/managers and state of the art technologies. Its unique microalgae-based solutions for agriculture are providing a fast growth globally, in terms of revenues, customers, contracts, attraction of top talent, awareness, research proposals and public awards.
8 commercial subsidiaries worldwide | >1 million final end-users | commercial contracts with market leaders | MoUs signed in 2020 | TRL: 9 | TAM: €64bn – SAM: €7.4 bn with 15% CAGR| Next Step: boost expansion| Amount to raise: €15m


Wednesday, April 29th 2020
Join the next Belgian e-pitch Session on May the 7th at 4:00pm
Our next  belgian e-pitch session will be held online on May the 7th at 4:00 PM CEST.
5 companies will be presented. selected 5 innovations looking to raise between 200K€ to 3M€ and working to build a more digital and sustainable world. Each entrepreneur will have 8 minutes to convince you to invest before you submit questions.

Register here

Digital therapies for higher efficiency of care
A secured platform that enables hospitals to implement digital care pathways that optimise patient flow and increase quality of care. The solution guides, monitors and coaches patients from before hospital admission up until the end of their recovery. Data driven techniques insure that patients get the correct advise at the correct time, and that care is provided in the most efficient way.
The solution is active in orthopaedics, bariatric and Covid-19.  It is used by 10+ hospitals in Belgium and expanding in UK, NL and FR, and has contracted with 3 medical device companies | 3 M€  sought of which 1 M€ committed
Organic Food that brings me back to my roots
Our productions are organic, local, seasonal and handmade: jams, tapenades, chutneys, preserved lemons…excellence in glass jars that are making use of different preservation processes.
Old fashioned?  Indeed, we make it slow…following the rhythm of Mother Nature, our jams are gently heated over 2 days. We have a simple ambition: making you feel this extra touch of soul and pleasure every day, around the clock.
Distribution in Organic stores and delicatessen stores in Belgium. Exported to Germany, Austria, Luxembourg and Japan | 300k€ sought of which 130k€ already raised
Eco building : turning construction waste in material
The construction sector is the most polluting sector in the world: responsible for 30% of global waste, 1/3 of air pollution, and up to 40% of the carbon emissions. We use one of these 'waste' streams, excavated earth, to transform them into healthy and beautiful circular building materials, such as rammed earth, clay plasters and compressed earth blocks. Currently, we are  the first and only operational circular building material producer with excavated earth in Europe. Our products are a CO2 neutral alternative for 14% in weight of the current building materials market. Target: all building professionals (building companies, contractors, architects, project developers and public clients) | 300k€ sought
Healthcare for children
A platform of apps and games reducing the stress and pain of children at hospital as well as the associated costs. 2 out 3 children are stressed during hospitalization. As a result, the experience is painful for the children and parents. An early bad experience will continue during the whole life and is expensive for the hospital. With our app, you can reduce the number of stressed children by 2 as the costs associated to the contention of the children.
280 k€ sought 
Fashion Tech / Influencer Marketing
Our mobile app allows users to scan barcode of apparels in stores to see all influencers wearing them, to read and write reviews and save a shopping session. It is a complete fashion social and shopping network, that connects brands, users and influencers through a curated technology that allows influencers to post pictures of their outfits and tag their clothes so that users can buy them. Users and influencers that generate content on the app are rewarded through affiliate marketing.
Partnership with Marie-Claire and Elle Belgium ; 20k+ app users  | 200k€ sought

Monday, April 27th 2020

EuroQuity selects the best eight European companies that have recently received a Seal of Excellence certificate.

Eight Seal of Excellence companies will be pitching next 12th of May at 5:00 PM CEST
A selection of 8 companies among the best European Seal of Excellence companies, all looking for funding from  1M€ to 15M€ will be pitching for 5 minutes each next Tuesday, May 12that 5 pm CEST.
All Seal of Excellence companies were certified by the European Commission thanks to their high potential innovation business plan that passed the threshold of selection of SME Instrument call (only 7% get financed).

This session is dedicated to diverse industries such as HealthTech, IoT, FoodTech, CleanTech, New Materials, Smart factories, check the program below.

If your schedule is too busy, you will still be able to watch the recorded session by registering.

Don’t miss it!

New materials / Chemistry / GreenTech
We make graphene-based formulations for protective coatings. Our goal is to partially or totally replace chromium and toxic metals in all industrial coatings. Our first markets are the building/infrastructure industry as well as the aeronautic industry. 20 contracts with several global industrial companies in the field of aeronautics, buildings, automotive, electronics and space industries. Winner of the ILab2019 award and the ESA BIC award. Winner of the CETIM Innovation challenge. Finalist of the 2018 JEC World Startup challenge & 2019 Industry of future challenge | TRL : 6-8 | TAM : €16B | Next Step : industrialization | 2.5M€ sought – France

HealthTech / PseudoPatient
The first FDA-cleared, patient-specific, anatomically-exact model of human head and brain tissue, offered to Radiotherapy clinics for simulating radiation therapy for each patient ahead of actual treatment in a totally risk-free environment, thus maximizing cancer patient safety and treatment effectiveness. This solution is also sold to RT equipment manufacturers for machine-testing purposes (contracted with Elekta A.B.). R&D 100 Award winner 2019, 1st prize MIT Enterprise Forum |TRL: 6-8 | TAM: €6B | Next step: commercial acceleration | €3M sought – Greece    

MedTech / Antimicrobial / Coating
A unique and universal antimicrobial coating to prevent healthcare-associated infections with the use of medical devices. Drug and metal-free technology reducing the risk of promoting bacterial resistance.
NDA and MTA signed with major manufacturers of medical devices (turnover of $4bn - $9bn) – License and joint development agreement under negotiation - Awarded grants from the Swedish Innovation Agency four times. | TRL : 6-8 | TAM : $1B (CAGR 14%) | Next Step : industrialization | 2M€ sought – Sweden

We developed a new cooling technology - Dynamic Air Cooling and construct cold generators which do not use any chemical or water refrigerants and have neither thermal nor CO2 emissions.  
Winner of KyivTechHub Startup Competition- Winner of European Startup Festival (Pitching Match London)-Winner of a Poland Prize Program – Winner of Sustainable Fast Track UK Award by Department of International Trade of UK. | TRL : 4-5 | TAM (beachhead only): $7,2B | Next Step: trials with customers | 2.7M€ sought – Poland

Automotive / Zero-Emission Propulsion / Hydrogen 
We convert conventional combustion engines to zero-emission hydrogen engines for OEMs with a combination of modular hard- and software components. Our technology can then be integrated into the OEMs series production line fast and cheaply. The technology is manufacturer independent and can thus be scaled almost indefinitely.
Pilot projects with three renown European engine manufacturers – Winner of the German Innovation Award’18 – #SET100 Certified Top 100 energy start-ups 2020 | TRL : 6-7 | TAM : $35B | Next Step: industrialisation & scale-up | 15M€ sought – Germany

Smart factories / Agility in production
We have developed and marketed a programmable robotized flexible fixture for manufacturing processes such as welding, assembly, it adds more flexibility in change over in production and agility to react quickly to market demand.
One of our clients,  testing the solution, is a major German automaker and we are discussing with a Spanish automaker. Finalist of European funding program DIH2. Next steps: finalize development and commercialisation at a higher level. | 1M€ sought – Denmark

CleanTech / AgriTech
Our solution recycles used agricultural geotextiles through an innovative dry recycling process. Respectful of the environment and saving resources, this technology enables the production of high- quality polymer granules (rPP & rPEHD) that can be reused in closed loop. 
Selected by WIPO to exhibit at COP21 - ETV in 2019 - Seal of excellence H2020 SME2 in 2019 - Solar impulse label in April 2020 -
TRL : 6-8 | TAM (total addressable market) : 1.95 B€ | Next Step : industrialization | 1.8M€ sought – France

Medtech / Healthtech

The first affordable medically relevant and comfortable wearable device that enables the mass detection of sleep apnea.
It drastically reduces diagnosis costs from € 1’500 to € 100 and, waiting list from 1 year to 1 day.
Bilan 2019 top 50 Swiss startups winner, EarlyMetrics score 71/100, Innosuissse Award and, EU Seal of Excellence Award.
TAM € 5B; SAM € 100M / year; Next step: CE Marking. € 500k to € 1M sought. - Switzerland

Thursday, April 23rd 2020
1 2 3 4 5 » ... 12
Stay informed by suscribing to our newsletter